INSR and Hepatic steatosis: As activation of hepatic CB1R signaling has been implicated in the development of insulin resistance, hyperglycemia, and hepatic steatosis, targeted inhibition of hepatic CB1R signaling might provide therapeutic approaches to restore insulin receptor signaling and improve hyperglycemia and hepatic steatosis.